Company profile
CARsgen Therapeutics Holdings Limited
2171 · HKEX (Verified via web search: listed on the Hong Kong Stock Exchange Main Board since June 2021 under stock code 2171, a CAR-T cell therapy developer headquartered in Shanghai. Sources: https://clinicaltrials.gov/study/NCT03915184 Entity resolved by asset-pipeline-v2.)
Public Market Listing
Live quotes, historical charts, and market capitalization for CARsgen Therapeutics Holdings Limited are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
| Target & Modality | |||
|---|---|---|---|
| Approved | BCMACell therapy | Multiple Myeloma | |
| Phase 2 | GPRC5DCell therapy | Multiple Myeloma |
Upcoming events
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.